BUSINESSDAILY MAIL US
The peptide beauty boom could be worth $2.2billion more... but one FDA decision could spell doom
The peptide beauty boom could increase in value by $2.2 billion, but a potential FDA decision may pose a significant risk to its growth. The outcome of this regulatory action could determine the industry's future success.
Related Signal
Adjacent reporting
- RFK Jr.'s peptide push could become next wellness boom
- ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
- Thinking about peptides? Doctors reveal key dos and don’ts as ‘Wild West’ market grows
- Peptides may soon be easier to get amid RFK Jr's push, but experts warn of risks
- 'Looksmaxxing' Trend Spawns $100M Gray Market Fueled By Bitcoin, Stablecoins: Chainalysis